Seems to me that there is a basis for imposing some level of control on the prices charged for patented medicines. Generally, price controls are anathema to an efficient free market; however, in the case of patented medicines, the market is already significantly distorted by non-market forces (i.e., by the government) and therefore some degree of price control would not represent an initial interference in an otherwise uncontrolled market.